Danielle Hammond, MD(@DanielleHammo20) 's Twitter Profileg
Danielle Hammond, MD

@DanielleHammo20

Leukemia doc at MD Anderson 🇺🇸 focusing on MDS-CH-VEXAS. Ex-pat 🇨🇦. Believe in the transformative power of compassion and science. Love puns! Views my own.

ID:4246291953

calendar_today22-11-2015 02:03:14

4,3K Tweets

2,4K Followers

1,6K Following

Follow People
David Fajgenbaum, MD(@DavidFajgenbaum) 's Twitter Profile Photo

Deadly hyperinflammatory disease finds curative treatment from a repurposed drug!

DADA2, a rare hyperinflammatory condition, tragically forces children to endure strokes at a young age, often leading to premature death in their teenage years.

Without a single clinical trial,…

account_circle
Mrinal Patnaik(@MrinalPatnaik) 's Twitter Profile Photo

The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance ashpublications.org/bloodadvances/… Mayo Clinic Comprehensive Cancer Center

account_circle
Pradeep Natarajan(@pnatarajanmd) 's Twitter Profile Photo

TET2 clonal hematopoiesis is enriched among individuals receiving solid organ transplantation. While this didn't predict transplant outcomes, whether it plays a role in the ultimate transplant indication requires further study aacrjournals.org/clincancerres/… AACR Alex Silver

account_circle
Naveen Pemmaraju, MD(@doctorpemm) 's Twitter Profile Photo

Rusfertide, a Mimetic, for Control of Erythrocytosis in Polycythemia Vera | New England Journal of Medicine | ⁦NEJM⁩ | ⁦Marina Kremyanskaya, MD, PhD⁩ ⁦Andrew Kuykendall MD⁩ ⁦Naveen Pemmaraju, MD⁩ et al nejm.org/doi/full/10.10…

account_circle
Taha Bat, MD(@md_bat) 's Twitter Profile Photo

Our “Ahemolytic PNH letter” published; please consider PNH flow in cases of thrombosis and BMF even no signs of hemolysis. Thanks Ibrahim Ibrahim, M.D. Carmelo Gurnari Bhavisha Patel Waled Bahaj, MD Olisaemeka Ogbue, MD for your contributions. onlinelibrary.wiley.com/doi/10.1111/bj…

account_circle
Daniel Kraft, MD(@daniel_kraft) 's Twitter Profile Photo

A study published today in the NEJM found that a blood test from Guardant Health searching for cell-free DNA from Colon Cancers detected 87% of cancers that were at an early and curable stage. The false positive rate was 10%.

nejm.org/doi/full/10.10…

account_circle
Waggoner Lab(@LabWaggoner) 's Twitter Profile Photo

CD19 CAR T-cell transfer appeared to be feasible, safe, and efficacious in three different autoimmune diseases (SLE, idiopathic inflammatory myositis, systemic sclerosis) NEJM
nejm.org/doi/pdf/10.105…

CD19 CAR T-cell transfer appeared to be feasible, safe, and efficacious in three different autoimmune diseases (SLE, idiopathic inflammatory myositis, systemic sclerosis) @NEJM nejm.org/doi/pdf/10.105…
account_circle
Caitlin Rausch(@CRausch_PharmD) 's Twitter Profile Photo

Ivosidenib significantly reduces voriconazole and posaconazole levels when given concomitantly. 🎉 Proud of Ashley Dinh for all of her hard work! MD Anderson Cancer Center

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

account_circle
José Javier Fuster(@josejfuster) 's Twitter Profile Photo

Time to update my hematopoiesis slides! Two papers now online at describe an association between @CHIP and cardiac arrythmias. Delighted to write the editorial comment with Domingo Pascual-Figal Marian Zuriaga: bit.ly/3whhO2D

account_circle
Christina Farr(@chrissyfarr) 's Twitter Profile Photo

Just so ya'll know, a group of physicians have been quietly making real progress on fixing prior authorization. Check out what's been happening in New Jersey. It's small, but it's something. 👇

Tina Shah STAT Nisha Mehta, MD Devika Bhushan, MD

Just so ya'll know, a group of physicians have been quietly making real progress on fixing prior authorization. Check out what's been happening in New Jersey. It's small, but it's something. 👇 @TinaShahMD @statnews @nishamehtamd @DrDevikaB
account_circle
Nitin Jain(@NitinJainMD) 's Twitter Profile Photo

👉👉Exactly 10 yrs to the day, ibrutinib was approved for patients with relapsed CLL. This was the start of a paradigm shift in CLL Rx👏👏

👉👉BTKi remain one of the most effective drugs in CLL and now we are increasingly using 2nd gen and non covalent BTKi

👉👉Exactly 10 yrs to the day, ibrutinib was approved for patients with relapsed CLL. This was the start of a paradigm shift in CLL Rx👏👏 👉👉BTKi remain one of the most effective drugs in CLL and now we are increasingly using 2nd gen and non covalent BTKi
account_circle
Elliot Tapper(@ebtapper) 's Twitter Profile Photo

It’s a landmark in the history of NASH (MASH)

A positive trial: less fibrosis, less inflammation, lower LDL

Something to celebrate

nej.md/4bHd7iT

It’s a landmark in the history of NASH (MASH) A positive trial: less fibrosis, less inflammation, lower LDL Something to celebrate nej.md/4bHd7iT #livertwitter
account_circle
Venky (Venkatraman Radhakrishnan)(@venkymd) 's Twitter Profile Photo

Time to move away from Dexamethasone for prevention of chemotherapy induced nausea and vomiting (CINV).

✅ Phase 3 double blind RCT
✅ DEX free prophylaxis is effective
✅ Lesser side effects like insomnia

ascopubs.org/doi/10.1200/GO…
JCO Global Oncology

account_circle